Autifony attracts £10 million for hearing loss treatment
Biotechnology company Autifony Therapeutics has closed a £10 million financing, securing a £5 million investment each from Imperial Innovations and SV Life Sciences.
News
Biotechnology company Autifony Therapeutics has closed a £10 million financing, securing a £5 million investment each from Imperial Innovations and SV Life Sciences.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software